Rhythm Pharmaceuticals to Announce Topline Results from Pivotal Phase 3 TRANSCEND Trial Evaluating Setmelanotide in Patients with  Acquired Hypothalamic Obesity

4 months ago 10
Read Entire Article
  1. Homepage
  2. Finance
  3. Rhythm Pharmaceuticals to Announce Topline Results from Pivotal Phase 3 TRANSCEND Trial Evaluating Setmelanotide in Patients with  Acquired Hypothalamic Obesity

Related

Taiwan's Yageo raises offer price for Japan's Shibaura to 7,130 yen/share to further outbid rival

Taiwan's Yageo raises offer price for Japan's Shibaura to 7,...

32 minutes ago 0
Exclusive-Syria to revalue currency, dropping two zeros in bid for stability

Exclusive-Syria to revalue currency, dropping two zeros in b...

32 minutes ago 0
Lyle Menendez denied parole after 35 years in prison for parents' shotgun murders

Lyle Menendez denied parole after 35 years in prison for par...

32 minutes ago 0

Trending

1. mariners game
2. kevin borjas
3. college gameday week 0
4. diyar nurgozhay
5. pete crow armstrong
6. adam kinzinger
7. mike trout
8. jessica biel
9. kenley jansen
10. tiffany haddish

Popular

College football by the odds: Vegas picks and preview of Ohio State vs. Notre Dame

College football by the odds: Vegas picks and preview of Ohi...

7 months ago 471
What to do in Las Vegas this week: January 2-8

What to do in Las Vegas this week: January 2-8

7 months ago 231
Australian whose blood saved 2.4 million babies dies

Australian whose blood saved 2.4 million babies dies

5 months ago 194
What is Tren de Aragua, the Venezuelan gang targeted by Trump?

What is Tren de Aragua, the Venezuelan gang targeted by Trum...

5 months ago 179
Taiwan slightly cuts 2025 GDP growth outlook amid Trump tariffs concern

Taiwan slightly cuts 2025 GDP growth outlook amid Trump tari...

5 months ago 176
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Sincity Press 2025. All rights are reserved